{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:06:03Z","timestamp":1782864363942,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"MSCA4Ukraine project","award":["1233336"],"award-info":[{"award-number":["1233336"]}]},{"name":"European Union\u2019s Horizon 2020 Research and Innovation Programme under the Marie Sk\u0142odowska-Curie grant agreement","award":["823854"],"award-info":[{"award-number":["823854"]}]},{"name":"European Cooperation Science and Technology","award":["COST Action CA21164"],"award-info":[{"award-number":["COST Action CA21164"]}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/01408, PI22\/01834"],"award-info":[{"award-number":["PI19\/01408, PI22\/01834"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10096-026-05451-2","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:42:55Z","timestamp":1772804575000},"page":"1707-1720","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Use of reverse dot blot hybridization DNA-array and targeted next-generation sequencing for the detection of drug resistance in patients with tuberculosis: a prospective diagnostic accuracy study"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8780-9480","authenticated-orcid":false,"given":"Andrii","family":"Dudnyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadiia","family":"Tytarenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris Romero","family":"Andrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana","family":"Lytvyniuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olena","family":"Tolstova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan-Pau","family":"Millet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Casas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Antuori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly","family":"Ciobanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeriu","family":"Crudu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"5451_CR1","unstructured":"Tejaswini Dharmapuri Vachaspathi Tuberculosis Diagnostics. Pipeline Report (2024) Treatment Action Group [Internet]. https:\/\/www.treatmentactiongroup.org\/wp-content\/uploads\/2025\/02\/2024_pipeline_tb_diagnostics_final.pdf"},{"key":"5451_CR2","unstructured":"WHO consolidated guidelines on tuberculosis. Module 3: diagnosis \u2013 rapid diagnostics for tuberculosis detection, third edition. Geneva: World Health Organization (2024) Licence: CC BY-NC-SA 3.0 IGO. [Internet]. doi: https:\/\/www.who.int\/publications\/i\/item\/9789240089488"},{"key":"5451_CR3","doi-asserted-by":"publisher","unstructured":"de Vos M, Scott L, David A, Trollip A, Hoffmann H, Georghiou S et al (2021) Comparative Analytical Evaluation of Four Centralized Platforms for the Detection of Mycobacterium tuberculosis Complex and Resistance to Rifampicin and Isoniazid. J Clin Microb. [Internet] 18. [cited 2025 25];59: https:\/\/doi.org\/10.1128\/jcm.02168-20. doi: https:\/\/journals.asm.org\/doi\/10.1128\/jcm.02168-20doi: 10.1128\/jcm.02168-20","DOI":"10.1128\/jcm.02168-20"},{"key":"5451_CR4","doi-asserted-by":"publisher","unstructured":"Wan L, Guo Q, Wei J-H, Liu H-C, Li M-C, Jiang Y et al (2020) Accuracy of a reverse dot blot hybridization assay for simultaneous detection of the resistance of four anti-tuberculosis drugs in Mycobacterium tuberculosis isolated from China. Infectious Diseases of Poverty [Internet] 16. [cited 2025 26];9:38. https:\/\/doi.org\/10.1186\/s40249-020-00652-z","DOI":"10.1186\/s40249-020-00652-z"},{"key":"5451_CR5","doi-asserted-by":"publisher","unstructured":"Lin M, Chen Y-W, Li Y-R, Long L-J, Qi L-Y, Cui T-T et al (2022) Systematic evaluation of line probe assays for the diagnosis of tuberculosis and drug-resistant tuberculosis. Clinica Chimica Acta [Internet] 1. [cited 2026 12];533:183\u2013218. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0009898122012104 doi: https:\/\/doi.org\/10.1016\/j.cca.2022.06.020","DOI":"10.1016\/j.cca.2022.06.020"},{"key":"5451_CR6","unstructured":"Tuberculosis: diagnostics technology landscape. Geneva: Unitaid; 2017 [Internet]. doi: https:\/\/unitaid.org\/uploads\/2017-Unitaid-TB-Diagnostics-Technology-Landscape.pdf"},{"key":"5451_CR7","doi-asserted-by":"publisher","unstructured":"Butcher PD (2004) Microarrays for Mycobacterium tuberculosis. Tuberculosis [Internet] 1 [cited 2026 10];84:131\u20137 https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1472979204000186 doi: https:\/\/doi.org\/10.1016\/j.tube.2004.01.002","DOI":"10.1016\/j.tube.2004.01.002"},{"key":"5451_CR8","doi-asserted-by":"publisher","unstructured":"Molina-Moya B, Lacoma A, Prat C, Diaz J, Dudnyk A, Haba L et al (2015) AID TB resistance line probe assay for rapid detection of resistant Mycobacterium tuberculosis in clinical samples. J Infect [ Internet] 1. [cited 2025 6];70:400\u2013408. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0163445314003053 doi: https:\/\/doi.org\/10.1016\/j.jinf.2014.09.010","DOI":"10.1016\/j.jinf.2014.09.010"},{"key":"5451_CR9","doi-asserted-by":"publisher","unstructured":"Mokrousov I, Bhanu NV, Suffys PN, Kadival GV, Yap S-F, Cho S-N et al (2004) Multicenter evaluation of reverse line blot assay for detection of drug resistance in Mycobacterium tuberculosis clinical isolates. J Microbiol Methods [ Internet] 1. [cited 2026 12];57:323\u2013335. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S016770120400051X doi: https:\/\/doi.org\/10.1016\/j.mimet.2004.02.006","DOI":"10.1016\/j.mimet.2004.02.006"},{"key":"5451_CR10","doi-asserted-by":"publisher","unstructured":"Ane-Anyangwe I, Mbacham WF, Meriki HD, Pride T, Nkuo-Akenji T, Penlap VM et al (2016) The Use of the PCR-Based Dot-Blot Hybridization Assay to Detect Resistance Markers to Rifampicin and Streptomycin in Mycobacterium tuberculosis Isolates from the SW Region of Cameroon. J Tuberculosis Res [Internet] 7. [cited 2026 12];4:72\u201379. https:\/\/www.scirp.org\/journal\/paperinformation?paperid=67133 doi: https:\/\/doi.org\/10.4236\/jtr.2016.42009","DOI":"10.4236\/jtr.2016.42009"},{"key":"5451_CR11","doi-asserted-by":"publisher","unstructured":"Linger Y, Kukhtin A, Golova J, Perov A, Lambarqui A, Bryant L et al (2014) Simplified Microarray System for Simultaneously Detecting Rifampin, Isoniazid, Ethambutol, and Streptomycin Resistance Markers in Mycobacterium tuberculosis. J Clin Microbiol [Internet] 52:2100\u20132107 [cited 2026 12];. https:\/\/journals.asm.org\/doi\/10.1128\/jcm.00238-14doi:https:\/\/doi.org\/10.1128\/jcm.00238-14","DOI":"10.1128\/jcm.00238-14"},{"key":"5451_CR12","doi-asserted-by":"publisher","unstructured":"Havlicek J, Dachsel B, Slickers P, Andres S, Beckert P, Feuerriegel S et al (2018) Rapid Microarray-Based Detection of Rifampin, Isoniazid, and Fluoroquinolone Resistance in Mycobacterium tuberculosis by Use of a Single Cartridge. Journal of Clinical Microbiology [Internet] 24. [cited 2026 12];56: https:\/\/doi.org\/10.1128\/jcm.01249-17. doi: https:\/\/journals.asm.org\/doi\/10.1128\/jcm.01249-17doi: 10.1128\/jcm.01249-17","DOI":"10.1128\/jcm.01249-17"},{"key":"5451_CR13","doi-asserted-by":"publisher","unstructured":"Colman RE, Seifert M, De la Rossa A, Georghiou SB, Hoogland C, Uplekar S et al (2024) Evaluating culture-free targeted next-generation sequencing for diagnosing drug-resistant tuberculosis: a multicentre clinical study of two end-to-end commercial workflows. The Lancet Infectious Diseases [Internet] 29. [cited 2025 26]; https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1473309924005863 doi: https:\/\/doi.org\/10.1016\/S1473-3099(24)00586-3","DOI":"10.1016\/S1473-3099(24)00586-3"},{"key":"5451_CR14","doi-asserted-by":"publisher","unstructured":"Carpi G, Seifert M, Rossa AD la, Uplekar S, Rodrigues C, Tukvadze N et al (2025) Comparative assessment of line probe assays and targeted next-generation sequencing in drug-resistant tuberculosis diagnosis. eBioMedicine [Internet] 1 [cited 2026 12];119. https:\/\/www.thelancet.com\/journals\/ebiom\/article\/PIIS2352-3964(25)00319-6\/fulltextdoi: https:\/\/doi.org\/10.1016\/j.ebiom.2025.105875","DOI":"10.1016\/j.ebiom.2025.105875"},{"key":"5451_CR15","volume-title":"Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update","author":"WHO consolidated guidelines on tuberculosis","year":"2022","unstructured":"WHO consolidated guidelines on tuberculosis (2022) Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update. World Health Organization, Geneva. [Internet]https:\/\/iris.who.int\/bitstream\/handle\/10665\/365308\/9789240063129-eng.pdf?sequence=1"},{"key":"5451_CR16","volume-title":"27\u201329 October 2020","author":"Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis","year":"2021","unstructured":"Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis (2021) 27\u201329 October 2020. World Health Organization, Geneva. https:\/\/iris.who.int\/bitstream\/handle\/10665\/338776\/9789240018662-eng.pdf?sequence=1 [Internet]"},{"key":"5451_CR17","unstructured":"Technical manual for drug susceptibility testing of medicines used in the treatment of tuberculosis Geneva: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO. [Internet]. [cited 2023 20];doi: https:\/\/apps.who.int\/iris\/handle\/10665\/275469"},{"key":"5451_CR18","unstructured":"Web Annex C. Technical manual for culture-based drug susceptibility testing of antituberculosis drugs used in the treatment of tuberculosis. In: WHO operational handbook on tuberculosis. Module 3: diagnosis - rapid diagnostics for tuberculosis detection, third edition. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO [Internet]. doi: https:\/\/www.paho.org\/sites\/default\/files\/2024-04\/2024-cde-who-consolidated-handbook-tb-module-3-rapid-tx-web-annex-c.pdf"},{"key":"5451_CR19","unstructured":"Deeplex\u00ae M-TB From clinical sample to drug resistance profil. User manual. March 2023 - V5. [Internet]. doi: https:\/\/www.illumina.com\/content\/dam\/illumina\/gcs\/assembled-assets\/marketing-literature\/deeplex-myc-tb-user-manual\/user-guide-genoscreen-deeplex-myc-tb.pdf"},{"key":"5451_CR20","unstructured":"The use of next-generation sequencing technologies for the detection of mutations associated with drug resistance in Mycobacterium tuberculosis complex: technical guide [Internet]. [cited 2025 26];doi: https:\/\/www.who.int\/publications\/i\/item\/WHO-CDS-TB-2018.19"},{"key":"5451_CR21","unstructured":"Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance, 2nd ed [Internet]. [cited 2025 26];doi: https:\/\/www.who.int\/publications\/i\/item\/9789240082410"},{"key":"5451_CR22","doi-asserted-by":"publisher","unstructured":"Sun B, Sun Y (2021) Diagnostic performance of DNA microarray for detecting rifampicin and isoniazid resistance in Mycobacterium tuberculosis. Journal of Thoracic Disease [Internet] [cited 2026 10];13. https:\/\/jtd.amegroups.org\/article\/view\/54244 doi: https:\/\/doi.org\/10.21037\/jtd-21-913","DOI":"10.21037\/jtd-21-913"},{"key":"5451_CR23","doi-asserted-by":"publisher","unstructured":"Shimizu Y, Dobashi K, Yoshikawa Y, Yabe S, Higuchi S, Koike Y, et al (2008) Five-antituberculosis Drug-resistance Genes Detection Using Array System. J Clin Biochem Nutr [Internet] [cited 2026 10];42:228\u201334. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC2386526\/ doi: https:\/\/doi.org\/10.3164\/jcbn.2008033","DOI":"10.3164\/jcbn.2008033"},{"key":"5451_CR24","doi-asserted-by":"publisher","unstructured":"Clinical Evaluation of a Line-Probe Assay for Tuberculosis Detection and Drug-Resistance Prediction in Namibia | Microbiology Spectrum [Internet]. [cited 2026 13];doi: https:\/\/journals.asm.org\/doi\/https:\/\/doi.org\/10.1128\/spectrum.00259-22","DOI":"10.1128\/spectrum.00259-22"},{"key":"5451_CR25","doi-asserted-by":"publisher","first-page":"1255756","DOI":"10.3389\/fpubh.2023.1255756","volume":"11","author":"R Gopalaswamy","year":"2023","unstructured":"Gopalaswamy R, Kumar N, Vashistha H, Rajendran P, Kayesth J, Peravali CJ et al (2023) Comprehensive assessment of invalid and indeterminate results in Truenat MTB-RIF testing across sites under the national TB elimination program of India. Front Public Health 11:1255756. https:\/\/doi.org\/10.3389\/fpubh.2023.1255756","journal-title":"Front Public Health"},{"key":"5451_CR26","doi-asserted-by":"publisher","unstructured":"Dudnyk A, Hempel M, Lytvyniuk O, Liudkevych H, Matsera V, Nikitchenko T, et al (2024) Impact of line probe assay-based molecular testing on individualized treatment in patients with rifampicin-resistant tuberculosis: data from the prospective INNOVA4TB cohort study in Ukraine. Ther Adv Respir Dis [Internet] 1 [cited 2025 6];18:17534666241249841. https:\/\/doi.org\/10.1177\/17534666241249841 doi: 10.1177\/17534666241249841","DOI":"10.1177\/17534666241249841"},{"key":"5451_CR27","unstructured":"WHO operational handbook on tuberculosis. Module 3: diagnosis. Geneva: World Health Organization; 2025. Licence: CC BY-NC-SA 3.0 IGO. [Internet]. doi: https:\/\/www.who.int\/publications\/i\/item\/9789240110991"},{"key":"5451_CR28","doi-asserted-by":"publisher","unstructured":"Wood HN, Venken T, Willems H, Jacobs A, Reis AJ, Silva PEA da, Molecular drug susceptibility testing and strain typing of tuberculosis by DNA hybridization. PLOS ONE [Internet] 2019 [cited 2026 12];14:e0212064. doi: https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0212064doi: https:\/\/doi.org\/10.1371\/journal.pone.0212064","DOI":"10.1371\/journal.pone.0212064"},{"key":"5451_CR29","doi-asserted-by":"publisher","unstructured":"Lacoma A, Molina-Moya B, Prat C, Pimkina E, Diaz J, Dudnyk A et al (2015) Pyrosequencing for rapid detection of Mycobacterium tuberculosis second-line drugs and ethambutol resistance. Diagnostic Microbiology and Infectious Disease [Internet] 1 [cited 2025 6];83:263\u2013269. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0732889315002308 doi: https:\/\/doi.org\/10.1016\/j.diagmicrobio.2015.07.004","DOI":"10.1016\/j.diagmicrobio.2015.07.004"},{"key":"5451_CR30","doi-asserted-by":"publisher","unstructured":"Schwab TC, Perrig L, G\u00f6ller PC, la Hoz FFGD, Lahousse AP, Minder B et al Targeted next-generation sequencing to diagnose drug-resistant tuberculosis: a systematic review and meta-analysis. The Lancet Infectious Diseases [Internet] 2024 1 [cited 2025 28];24:1162\u20131176. doi: https:\/\/www.thelancet.com\/journals\/laninf\/article\/PIIS1473-3099doi: https:\/\/doi.org\/10.1016\/S1473-3099(24)00263-9","DOI":"10.1016\/S1473-3099(24)00263-9"},{"key":"5451_CR31","doi-asserted-by":"publisher","unstructured":"Mansoor H, Hirani N, Chavan V, Das M, Sharma J, Bharati M, et al (2023) Clinical utility of target-based next-generation sequencing for drug-resistant TB. Int J Tuberc Lung Dis [Internet] [cited 2025 28];27:41\u20138. doi: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9879084\/ doi: https:\/\/doi.org\/10.5588\/ijtld.22.0138","DOI":"10.5588\/ijtld.22.0138"},{"key":"5451_CR32","doi-asserted-by":"publisher","unstructured":"Development and Assessment of a Novel Whole-Gene-Based Targeted Next-Generation Sequencing Assay for Detecting the Susceptibility of Mycobacterium tuberculosis to 14 Drugs | Microbiology Spectrum [Internet]. [cited 2025 28];doi: https:\/\/journals.asm.org\/doi\/https:\/\/doi.org\/10.1128\/spectrum.02605-22","DOI":"10.1128\/spectrum.02605-22"},{"key":"5451_CR33","doi-asserted-by":"publisher","unstructured":"K\u00f6ser CU, Robledo J, Shubladze N, Sch\u00f6n T, Dolinger DL, Salfinger M (2021) Guidance is needed to mitigate the consequences of analytic errors during antimicrobial susceptibility testing for TB. Int J Tuberc Lung Dis 25:791\u20134. doi: https:\/\/doi.org\/10.5588\/ijtld.21.0428","DOI":"10.5588\/ijtld.21.0428"},{"key":"5451_CR34","doi-asserted-by":"crossref","unstructured":"Zhurilo OA, Chernov OV, Barbova AI, Lubevich RL, Trofimova PS, Yaremenko MS, et al (2025) Verification of the next-generation targeted sequenceing method using the Deeplex Myc-TB reagent kit (Genoscreen, Lille, France) for determining drug resistance of Mycobacterium tuberculosis in sputum samples. Ukr Pulmonol J. [Internet] 14 [cited 2026 11];33:23\u201323. doi: https:\/\/pulmonology-journal.com.ua\/index.php\/journal\/article\/view\/70","DOI":"10.31215\/2306-4927-2025-33-1-23-30"},{"key":"5451_CR35","doi-asserted-by":"publisher","unstructured":"Molina-Moya B, Guglielmetti L, Bothamley G, van Leth F, Lange C, Dominguez J et al (2021) Use and impact of molecular methods for detecting drug\u2010resistant TB. Int J Tuberc Lung Dis 25:157\u2013159. https:\/\/doi.org\/10.5588\/ijtld.20.0527","DOI":"10.5588\/ijtld.20.0527"},{"key":"5451_CR36","doi-asserted-by":"publisher","unstructured":"Ahmad Khosravi N, Khosravi AD, Hashemzadeh M, Savari M, Saki M (2025) Investigation of delamanid, bedaquiline, and linezolid resistance rates and related gene mutations in multidrug-resistant Mycobacterium tuberculosis in regional tuberculosis reference laboratories of Iran. BMC Microbiol [Internet] 15 [cited 2026 14];25:509. https:\/\/doi.org\/10.1186\/s12866-025-04213-ydoi","DOI":"10.1186\/s12866-025-04213-ydoi"},{"key":"5451_CR37","unstructured":"Global Tuberculosis Report 2024 [Internet]. [cited 2025 26];doi: https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2024"},{"key":"5451_CR38","doi-asserted-by":"publisher","unstructured":"Vasiliu A, Cristea V, Stoycheva K, Rosales-Klintz S, Lange C, Zenner D et al (2025) Shifting tuberculosis dynamics in the EU\/EEA: geographical and drug resistance trends among people of foreign origin, 2019 to 2023. Eurosurveillance [Internet] 20 [cited 2025 1];30:2500173. https:\/\/www.eurosurveillance.org\/content\/10.2807\/1560-7917.ES.2025.30.11.2500173 doi: https:\/\/doi.org\/10.2807\/1560-7917.ES.2025.30.11.2500173","DOI":"10.2807\/1560-7917.ES.2025.30.11.2500173"},{"key":"5451_CR39","doi-asserted-by":"publisher","unstructured":"Muthaiah M, Shivekar SS, Cuppusamy Kapalamurthy VR, Alagappan C, Sakkaravarthy A, Brammachary U (2017) Prevalence of mutations in genes associated with rifampicin and isoniazid resistance in Mycobacterium tuberculosis clinical isolates. J Clin Tuberc Other Mycobact Dis [Internet] 20 [cited 2025 26];8:19\u201325. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6850230\/ doi: https:\/\/doi.org\/10.1016\/j.jctube.2017.06.001","DOI":"10.1016\/j.jctube.2017.06.001"},{"key":"5451_CR40","doi-asserted-by":"publisher","unstructured":"Zhao L-L, Chen Y, Liu H-C, Xia Q, Wu X-C, Sun Q et al (2014) Molecular Characterization of Multidrug-Resistant Mycobacterium tuberculosis Isolates from China. Antimicrob Agents Chemother [Internet] [cited 2025 30];58:1997\u20132005. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4023728\/ doi: https:\/\/doi.org\/10.1128\/AAC.01792-13","DOI":"10.1128\/AAC.01792-13"},{"key":"5451_CR41","unstructured":"Merker M, Nikolaevskaya E, Kohl TA, Molina-Moya B, Pavlovska O, Br\u00e4nnberg P et al (2015) Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Beijing Clades, Ukraine. [cited 2025 19]; https:\/\/stacks.cdc.gov\/view\/cdc\/85667"},{"key":"5451_CR42","doi-asserted-by":"publisher","unstructured":"Noroc E, Chesov D, Merker M, Gr\u00f6schel MI, Barilar I, Dreyer V, et al (2023) Limited Nosocomial Transmission of Drug-Resistant Tuberculosis, Moldova - Volume 29, Number 5\u2014May 2023 - Emerging Infectious Diseases journal - CDC. [cited 2026 14];doi: https:\/\/wwwnc.cdc.gov\/eid\/article\/29\/5\/23-0035_article doi: https:\/\/doi.org\/10.3201\/eid2905.230035","DOI":"10.3201\/eid2905.230035"},{"key":"5451_CR43","doi-asserted-by":"publisher","unstructured":"Cancino-Mu\u00f1oz I, L\u00f3pez MG, Torres-Puente M, Villamayor LM, Borr\u00e1s R, Borr\u00e1s-M\u00e1\u00f1ez M et al (2022) Population-based sequencing of Mycobacterium tuberculosis reveals how current population dynamics are shaped by past epidemics. eLife [Internet] 26 [cited 2026 14];11:e76605. https:\/\/doi.org\/10.7554\/eLife.76605doi","DOI":"10.7554\/eLife.76605doi"},{"key":"5451_CR44","doi-asserted-by":"publisher","unstructured":"Micheni LN, Kassaza K, Kinyi H, Ntulume I, Bazira J (2022) Detection of Mycobacterium tuberculosis multiple strains in sputum samples from patients with pulmonary tuberculosis in south western Uganda using MIRU-VNTR. Sci Rep [Internet] 31 [cited 2025 6];12:1656. https:\/\/www.nature.com\/articles\/s41598-https:\/\/doi.org\/10.1038\/s41598-022-05591-3","DOI":"10.1038\/s41598-022-05591-3"},{"key":"5451_CR45","doi-asserted-by":"publisher","unstructured":"Sibandze DB, Kay A, Dreyer V, Sikhondze W, Dlamini Q, DiNardo A et al (2022) Rapid molecular diagnostics of tuberculosis resistance by targeted stool sequencing. Genome Med [Internet] 19 [cited 2025 6];14:52. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9118838\/ doi: https:\/\/doi.org\/10.1186\/s13073-022-01054-6","DOI":"10.1186\/s13073-022-01054-6"},{"key":"5451_CR46","doi-asserted-by":"publisher","unstructured":"Dom\u00ednguez J, Boeree MJ, Cambau E, Chesov D, Conradie F, Cox V et al Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet\/RESIST-TB consensus statement. The Lancet Infectious Diseases [Internet] 2023 1 [cited 2025 30];23:e122\u2013137. doi: https:\/\/www.thelancet.com\/journals\/laninf\/article\/PIIS1473-3099(22)00875-1\/abstractdoi: https:\/\/doi.org\/10.1016\/S1473-3099(22)00875-1","DOI":"10.1016\/S1473-3099(22)00875-1"},{"key":"5451_CR47","doi-asserted-by":"publisher","unstructured":"Kang JY, Hur J, Kim S, Jeon S, Lee J, Kim YJ et al (2019) Clinical implications of discrepant results between genotypic MTBDRplus and phenotypic L\u00f6wenstein-Jensen method for isoniazid or rifampicin drug susceptibility tests in tuberculosis patients. J Thorac Dis [Internet]. [cited 2025 2];11:400\u20139. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6409268\/ doi: https:\/\/doi.org\/10.21037\/jtd.2019.01.58","DOI":"10.21037\/jtd.2019.01.58"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-026-05451-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-026-05451-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-026-05451-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:42:10Z","timestamp":1782862930000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-026-05451-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["5451"],"URL":"https:\/\/doi.org\/10.1007\/s10096-026-05451-2","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"26 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the independent ethics committees at each clinical site where patients were recruited: National Pirogov Memorial Medical University (protocol \u21165, 03.07.2018); Regional Center of Socially Significant Diseases (protocol N1232, 11.07.2018); Germans Trias i Pujol Hospital (PI19\/01408); and PMSI Institute of Pneumology \u201cChiril Draganiuc\u201d (protocol N\u00baI4TB, 24.06.2019). All patients provided written informed consent prior to sample collection and study participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}